Presenting Author: Lin-Chieh Meng – Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania
### @@@ Charles E. Leonard, PharmD, MSCE, FISPE – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania ### 2642019###Co-Author###Associate Professor###Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania###Co-Author: Charles E. Leonard, PharmD, MSCE, FISPE – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania
### @@@ Molly Candon – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania ### 2642020###Co-Author######Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania###Co-Author: Molly Candon – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
### @@@ David Mandell – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania ### 2642021###Co-Author######Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania###Co-Author: David Mandell – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
### @@@ Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania ### 2642288###Co-Author###Professor###Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania###Co-Author: Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania
### 4F-03Presenting Author: Kevin Pritchard – Brigham and Women's Hospital
### @@@ Mitra McLarney – Harvard Medical School ### 2642471###Co-Author######Harvard Medical School###Co-Author: Mitra McLarney – Harvard Medical School
### @@@ Stephen Wechsler – Simmons University ### 2642472###Co-Author######Simmons University###Co-Author: Stephen Wechsler – Simmons University
### @@@ Sadaf Arefi Milani – University of Texas Medical Branch ### 2642473###Co-Author######University of Texas Medical Branch###Co-Author: Sadaf Arefi Milani – University of Texas Medical Branch
### @@@ Kathleen Doyle Lyons – MGH Institute of Health Professions ### 2642474###Co-Author######MGH Institute of Health Professions###Co-Author: Kathleen Doyle Lyons – MGH Institute of Health Professions
### 2A-03Presenting Author: Michele Jonsson Funk, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Jennifer L. Lund, PhD, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 2641535###Co-Author###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Jennifer L. Lund, PhD, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ Donna Rivera, PharmD., MSc., FISPE – University of Maryland ### 2641576###Co-Author###Former FDA/ Affiliate Associate Professor###University of Maryland###Co-Author: Donna Rivera, PharmD., MSc., FISPE – University of Maryland
### @@@ Gerd Rippin, PhD – IQVIA ### 2641577###Co-Author###Senior Director, Real World Solutions, Statistical Services, IQVIA###IQVIA###Co-Author: Gerd Rippin, PhD – IQVIA
### @@@ Catherine C. Lerro, PhD, MPH – Oncology Center of Excellence ### 2641578###Co-Author###Senior Epidemiologist###Oncology Center of Excellence###Co-Author: Catherine C. Lerro, PhD, MPH – Oncology Center of Excellence
### @@@ Ann Marie McNeill, PhD, MPH – AbbVie ### 2641579###Co-Author###Senior Director, Oncology TA, Global Epidemiology###AbbVie###Co-Author: Ann Marie McNeill, PhD, MPH – AbbVie
### @@@ Jennifer S. Fusco – Epividian, Inc. ### 2641580###Co-Author###President###Epividian, Inc.###Co-Author: Jennifer S. Fusco – Epividian, Inc.
### SW-3ACo-Moderator: Alexandra Z. Sosinsky, ScM – Genesis Research Group, Hoboken, NJ, USA
### @@@ Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA ### 1655874###Co-Moderator###Associate Professor###University of San Francisco, San Francisco CA, USA###Co-Moderator: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA
### she/her/hers 2GCo-Moderator: Constanza L Andaur Navarro – Julius Center, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands
### @@@ Katherine Donegan, PhD – Genesis Research Group ### 2644577###Co-Moderator###Director, Pharmacoepidemiology and Safety###Genesis Research Group###Co-Moderator: Katherine Donegan, PhD – Genesis Research Group
### 1D